Loading edition detail...
Preparing this view.
O.R. Hommes, G. Comi
Early diagnosis is a new challenge for the neurologist, as demonstrated by the advantages of early treatment of multiple sclerosis with interferon beta. The rationale for early treatment is extensively reviewed together with the mechanism underlying irreversible damage in MS.
| Edition | 1 edition |
|---|---|
| Publisher | Springer |
| Pages | 200 |
| Format | Hardcover |
| Search language | english |
| ISBN_10 | 8-847-00195-1 primary |
| ISBN_13 | 978-8-847-00195-4 primary |
Publication-specific alternatives linked to the same work.
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
Early indicators, early treatment, neuroprotection in multiple sclerosis
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
Early indicators, early treatments, neuroprotection in multiple sclerosis